Image

Comparison of Three Different Puncture Techniques in EBUS-TBNA

Comparison of Three Different Puncture Techniques in EBUS-TBNA

Non Recruiting
18-80 years
All
Phase N/A

Powered by AI

Overview

The purpose of this study was to compare the accuracy and sensitivity of slow-pull capillary technique, traditional suction aspiration and non negative pressure puncture in the diagnosis of mediastinal and/or hilar lymph node enlargement by ultrasound bronchoscopic lymph node biopsy.

Description

EBUS-TBNA has been widely used in the diagnosis of diseases involving lung hilar and mediastinal lymph node enlargement.But different puncture methods are still controversial. Research shows that there was no significant difference in sample adequacy, diagnostic specificity and accuracy between the no negative pressure aspiration and traditional negative pressure aspiration technique.Slow-pull capillary technique is a relatively new operating method of endoscopic ultrasound guided fine needle biopsy in recent years. At present, this technology is widely used in pancreatic space occupying lesions. Compared with the traditional negative pressure aspiration method, our previous retrospective study found that the slow-pull capillary technique can improve the diagnostic accuracy of patients. Therefore, the purpose of this study is to prospectively and randomly compare the advantages and disadvantages of three puncture methods in EBUS-TBNA.

Eligibility

Inclusion Criteria:

  • Age 18-80years
  • Chest computed tomography showing hilar or mediastinal lymph node enlargement
  • No contraindications for bronchoscopy
  • Signed informed consent provided by the patient
  • Disease needs to be diagnosed through the EBUS-TBNA

Exclusion Criteria:

  • Severe coagulation dysfunction
  • Severe cardiopulmonary dysfunction
  • Acute asthma attack or massive haemoptysis
  • Poor general condition
  • Physical weakness without tolerance for anaesthesia or allergy to narcotic drug
  • Disease can be diagnosed by other less invasive methods (such as skin or peripheral superficial lymph node biopsy)

Study details
    Lung Cancer
    Sarcoidosis
    Tuberculosis

NCT05628454

Beijing Friendship Hospital

20 August 2025

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.